Concerns growing over higher pharma raw material prices

The prices of pharmaceutical raw materials, rising at a faster-than-expected pace this year, have forced drug makers to re-establish their marketing plan for each of ethical products.

Pharmaceutical firms are in dilemma how to reflect the price hike, but they feel it is actually “impossible” to do so due to the government’s rigid drug pricing policy.

Should the prices of pharmaceutical ra...